Albuquerque, NM and San Diego, CA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Exagen, a leader in autoimmune life sciences, today announced that it will present at the Cowen and Company 39th Annual Health Care Conference being held March 11-13, in Boston, MA. Ron Rocca, President and CEO, will present an overview of the company, including the patented cell-bound complement activation products (CB-CAPs) technology and other recent advances for the AVISE brand of testing on Tuesday, March 12 at 3:00 p.m. ET.  About Exagen Inc. Exagen is a commercial stage life sciences company that is patient-focused and discovery driven. We serve patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. By leveraging our patented and validated technologies we can help get to the real cause of a patient’s symptoms and guide their journey to improved health. For more information visit, www.exagen.com  or follow us on  Facebook ,  Twitter ,  YouTube ,  LinkedIn , or  Instagram .

Kamal Adawi Exagen, Inc. 760.477.5514 IR@exagen.com